News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
About the Author - Mark Terry

news@biospace.com

BioSpace News - By Mark Terry
Long-Time NIH Scientist to Head Up Early Discovery at Pfizer (PFE) Unit 8/18/2017
Meet the BioPharma Vet Frantically Raising Cash for His Biotech Startup Engage Therapeutics 8/18/2017
The 3 Absolute Best Biotech Stocks Right Now 8/18/2017
Biogen (BIIB) Gained $1 Billion Overnight After Becoming Goldman Sachs' Favorite Biotech 8/17/2017
Novo Nordisk A/S (NVO)’s Diabetes Drug Beats Out Eli Lilly (LLY)’s Trulicity in Phase III Trials 8/17/2017
Novartis AG (NVS) Lures Superstar Scientist Away From UCSF 8/17/2017
Bristol-Myers Squibb (BMY)'s Stock Topples as Kidney Cancer Drug Flunks Phase III Study 8/16/2017
Gilead (GILD) to Unveil New SoCal Facility That Could House Up to 500 Employees 8/16/2017
Why Gilead (GILD) Might Not Make an Oncology Buy After All 8/16/2017
Amazon (AMZN)'s Possible Strategy for Breaking Into the $560 Billion Pharma Market 8/15/2017
Sihuan Pharma Opens Up R&D Shop in the San Francisco Bay Area 8/15/2017
FDA Puts in Place New Hiring Protocols for Foreign Scientists 8/15/2017
Warning for Scientists: Scammers are Giving Away NIH Grants 8/15/2017
Pharma Giant Bristol-Myers Squibb (BMY) Plans Layoffs, Effective Oct. 6 8/15/2017
Ophthotech (OPHT)'s Wet AMD Drug Fails to Meet Primary Endpoint in Phase III Study 8/15/2017
130 Jobs Affected as Merck KGaA (MKGAF.PK) Relocates Accounting, Book-Keeping Team to Cut Costs 8/14/2017
Bleeding Money, Patrick Soon-Shiong’s NantHealth (NH) Restructures and Lays Off 300 8/14/2017
Novogen (NVGN) Restructures, Board to Take Pay Cuts 8/14/2017
Former Pfizer (PFE) Scientist-Led Startup Zai Lab Taps Banks for $150M IPO 8/14/2017
Pfizer (PFE)'s Expansion into Gene Therapy Adds Jobs with $90,000 Salaries 8/11/2017
GlaxoSmithKline (GSK) Ditches Ionis Pharma (IONS)'s Inotersen and IONIS-FB-LRx 8/11/2017
Celgene (CELG) Revamps Pact With Bay Area Biotech, No Acquisition Coming 8/11/2017
Regeneron (REGN) Heading for Another Hiring Ramp 8/11/2017
Happy Birthday, Vivek Ramaswamy—Here’s a $1.1 Billion Present 8/11/2017
Egalet Cuts Workforce By 40% in Expense Reduction Plan 8/10/2017
Bay Area’s Ardelyx (ARDX) Slashes 28% of Workforce in Restructuring 8/10/2017
Drumroll... New Company Prevail Therapeutics Launched 8/10/2017
Biopharma Provider SGS (SGSN) Creates New Jobs in 2017 Expansion 8/9/2017
Bay Area’s BioMarin (BMRN) Expands With The World's “First and Largest” Gene Therapy Manufacturing Plant 8/9/2017
Why Eli Lilly (LLY) Has the Strongest Reputation in the Life Sciences Industry 8/9/2017
MyoKardia Shares Surge on Positive Phase II Results for Heart Muscle Disease 8/8/2017
This Boston Biotech Just Got Scooped Up for $300M By Bristol-Myers Squibb (BMY) 8/8/2017
New York's Saptalis Expands Production into New 28,000 Sq. Ft. Plant 8/8/2017
3 Biotechs Whose Q2 Reports Exceeded Expectations 8/8/2017
CRO vs. Big Pharma: Which is the Better Place to Work? 8/7/2017
Acorda (ACOR) Investor Urges for Company to Explore Sale 8/7/2017
GlaxoSmithKline (GSK) to Shift Neuro R&D Out of China to Philadelphia Research Hub 8/7/2017
United Therapeutics (UTHR) Shares Surge on Report of Bids for Company 8/7/2017
Dynavax (DVAX) Shares Plunge on Delayed FDA Decision for Hep B Vaccine Heplisav 8/4/2017
According to Real Scientists, This is How You Get a Job in Biopharma 8/4/2017
Biotech Startup Indalo Therapeutics Nabs $9M 8/4/2017
With Baxalta (BXLT) Boosting Rare Drugs, Shire (SHPG) May Spin Off ADHD Drugs Business 8/4/2017
Seattle Genetics (SGEN) Nabs Bristol-Myers Squibb (BMY)’s Bothell MFG Facility, Plans to Offer Jobs to Current Employees 8/3/2017
Why You Want to Keep This Small $2 Biotech Stock On Your Radar 8/3/2017
Immuron CEO Thomas Liquard Resigns 8/3/2017
Agios (AGIO), Celgene (CELG) Win Early FDA Approval for New Cancer Drug 8/3/2017
Top 10 Biotech Employers in Massachusetts by Job Listings 8/3/2017
Geron (GERN) Under Pressure as Clinical Trial Changes Causes Delays 8/2/2017
LabCorp (LH) Scoops Up Giant CRO for Approximately $1.2 Billion Cash 8/1/2017
Adare Pharma to Expand Its Manufacturing and Formulation R&D, Expects to Create 29 Jobs 8/1/2017
4 Hot Biotech Stocks in 2017 8/1/2017
Massachusetts’ Homology Medicines Snags $83.5M to Advance AMEnDR into Human Trials 8/1/2017
3 Under $30: These Biotech Stocks to Shake Up the Industry 8/1/2017
Amazon (AMZN) Has Top Secret 1492 Unit Working on Healthcare and Telemedicine 8/1/2017
Clementia to Launch IPO, Despite So-So Phase II Trials and Investor Skepticism 8/1/2017
FDA Panel Votes to Recommend Dynavax (DVAX)'s Hepatitis B Vaccine; Hepsilav Can Compete With GlaxoSmithKline (GSK)'s Engerix-B 7/31/2017
2 Pharma Giants Pfizer (PFE) Could Make a Megadeal on Soon 7/31/2017
Illumina (ILMN) Accelerator in the Bay Area Makes Room for 5 New Biotech Startups 7/31/2017
CMOs Cringe as GlaxoSmithKline (GSK) Will be Cutting Its Use by 25% 7/31/2017
220 Employees Chopped as Astellas (ALPMY) Winds Down SoCal's Agensys, Inc. 7/28/2017
Rumor Alert: This Big Pharma Has Hired Bankers to Fend Off Deal-Hungry Suitors 7/28/2017
Alexion (ALXN) Redefines R&D Strategy, Discontinues Programs and Kills Deals With Moderna, Blueprint (BPMC) and Arbutus Biopharma (ABUS) 7/28/2017
Some GlaxoSmithKline (GSK) Critics Would Prefer Walmsley Broke Up the Company 7/28/2017
GlaxoSmithKline (GSK) CEO Kills 30+ Pre-Clinical and Clinical Programs 7/28/2017
Google (GOOG) Quietly Invests in This Cancer-Testing Startup, Builds Lab on Verily (GOOGL) Campus to Sweeten Deal 7/27/2017
Biogen (BIIB) May Cut Jobs, Shutter Facilities to Streamline Ops and Free Up $400 Million for R&D 7/27/2017
Eli Lilly (LLY) Shakes Up Cancer R&D Strategy, Seeks New Home for Seven Pipeline Drugs 7/26/2017
3 Biotechs With Positive Technical Stock Readouts Ahead of Q2 Reports 7/26/2017
Boehringer Ingelheim Aims for 300 New Bay Area Jobs With $217 Million Expansion 7/26/2017
5 Biotechs With $45 Billion Worth of Not-Yet Approved Drugs in the Pipeline 7/25/2017
Brace Yourself: GlaxoSmithKline (GSK)'s New CEO Gets Ready to Overhaul the Drug Pipeline 7/25/2017
10 Biotechs Tackling Senator John McCain's Form of Aggressive Brain Cancer 7/24/2017
Merz North America to Consolidate Three Facilities, Will Retain 165 Jobs and Hopes to Create More 7/24/2017
Corning (GLW), Merck & Co. (MRK) and Pfizer (PFE) to Invest $4 Billion and Create 4,000 New Jobs in the U.S. 7/24/2017
Kite Pharma (KITE) Touts Remissions Up to 56+ Months in Non-Hodgkin Lymphoma Patients on CAR T-Cell Therapy 7/21/2017
3 Sizzling Hot Biotech Stocks Only Likely to Get Hotter 7/21/2017
11 Life Science Skills You'll Need in 2020 7/21/2017
Can This Region Become the Country’s Next Big Biotech Hub for Jobs? 7/21/2017
Most Common Mistake Scientists Make When Applying for a Job 7/21/2017
Hundreds of Jobs to Go as GlaxoSmithKline (GSK) Shutters Manufacturing Site 7/21/2017
Uncertainty Hits as Roche (RHHBY) is Dealt Multiple Clinical Trial Setbacks 7/21/2017
3 Big Pharmas That Give Investors the Biggest Bang for the Buck 7/20/2017
New GlaxoSmithKline (GSK) CEO Wants to Dump Another Business as it Prioritizes Pharma 7/20/2017
2 Fast-Rising Biotech Stocks With No Competition in Sight 7/20/2017
Takeda (TKPYY) Axes Sales Jobs, Forces Hundreds of Employees to Relocate to Boston 7/20/2017
How Much Money Will These 5 Pharma Companies' Pipelines Generate in 5 Years 7/19/2017
3 Tiny Biotechs Packed With Top Execs With Proven Track Records 7/19/2017
Novartis AG (NVS) Boss Updates Q2 Financials and Reaffirms M&A Strategy 7/19/2017
Safety Issues Force the FDA to Turn Down Amgen (AMGN), UCB SA's Osteoporosis Drug 7/18/2017
Debt-Ridden Valeant (VRX) Dumps Another Asset in $190 Million Cash Deal 7/17/2017
This is the Fastest Growing Cancer Biotech No One Really Knows About 7/17/2017
How Biogen (BIIB) Makes Most of Its Cash 7/17/2017
Biotech Startup Ibex Biosciences Quietly Sets Up Shop in Maryland 7/17/2017
FDA Gives Nod to Johnson & Johnson (JNJ)'s Potential Blockbuster Psoriasis Med 7/17/2017
Novartis AG (NVS) Stocking Up on "Big-3" Arthritis Blockbusters to Get an Edge on Rivals 7/14/2017
FDA Panel Unanimously Endorses Novartis AG (NVS)'s CAR-T Leukemia Drug 7/14/2017
GlaxoSmithKline (GSK) Poaches Another Top Exec—This Time From Pfizer (PFE) 7/14/2017
Sanofi (SNY) Finally Closes a Deal, Pays $750 Million for This Connecticut Biotech 7/13/2017
San Diego's Arena (ARNA) Soars as Phase II Hypertension Trial Data Wows 7/13/2017
Why This Bay Area Pharma Could Win the Hemophilia Race With 'One And Done' Drug 7/13/2017
Bay Area's Galena Biopharma  (GALE) Slashes Jobs While Exploring Strategic Alternatives 7/12/2017
5 Best Biotech Stocks to Buy in the 2nd Half of 2017 7/12/2017
5 Cancer Drugs That Will Become Even Bigger Winners by 2022 7/12/2017
Booming C4 Therapeutics to Move Out of Pricey Kendall Square Next Year 7/12/2017
The 3 Biotechs That Could Make Celgene (CELG) Even Richer 7/11/2017
Why Amgen (AMGN) Needs an Acquisition to Keep Up with Immuno-Oncology Competitors 7/11/2017
Little-Known Emmaus Just Won Approval for First New Sickle Cell Drug in 20 Years 7/11/2017
CMC Biologics to Hire 100 to 150 Employees in Washington 7/10/2017
3 Under-the-Radar Biotech Clusters for Life Science Job Seekers 7/10/2017
What Does It Take to Get Hired by GlaxoSmithKline (GSK) and AbbVie (ABBV) 7/7/2017
Capricor (CAPR) Falls as Johnson & Johnson (JNJ) Bails on Stem Cell Heart Med 7/7/2017
Mark Your Calendars: 7 Biotechs Facing Important Catalysts in July 7/7/2017
Biotech Bestie Celgene (CELG) Takes Stake, Inks $1 Billion+ Deal With BeiGene (BGNE) 7/7/2017
Japan's Konica Minolta (4902) Takes Out SoCal Diagnostics Firm Ambry Genetics in $1 Billion Deal 7/7/2017
Effective Immediately: Advaxis (ADXS) CEO Resigns, Interim Leader Named 7/7/2017
Bristol-Myers Squibb (BMY)'s Opdivo Prevails in Phase III Melanoma Trial 7/6/2017
Top 9 Biotech Giants to Work for in New Jersey 7/6/2017
3 Biotechs With Bulging Pipelines That Could Also Become Attractive Takeover Targets 7/6/2017
5 Biotechs Awaiting Big News From the FDA in July 7/6/2017
Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug 7/6/2017
3 Key Reasons Why a Gilead (GILD)-Vertex (VRTX) Marriage May Not be a Match Made in Biotech Heaven 7/5/2017
Shire (SHPG) to Consolidate 3,000+ Jobs Over 4 Years to 2 Massachusetts Sites 7/5/2017
Roche (RHHBY) to Slash 75 Jobs in Massachusetts, More Consolidation to Come 7/5/2017
Pfizer (PFE) Expects to Hire 80 New Staffers After Completion of $200 Million R&D Facility 6/30/2017
Takeda (TKPYY) CEO Faces Increasing Pressure From Investors as His Closest Ally Retires 6/30/2017
New Sarepta (SRPT) CEO's M&A Experience Sparks Sale Speculation 6/30/2017
FDA Approval of Drug May Have Made This Bay Area Pharma a New M&A Target 6/30/2017
Omeros (OMER) Pursuing Legal Action Against Short Seller for Report That Caused Stock to Tank This Week 6/30/2017
Sarepta (SRPT) Taps Allergan (AGN) Alum as New CEO 6/29/2017
Merck & Co. (MRK)'s Midas Touch Continues as Heart Drug Succeeds Where Pfizer (PFE), Eli Lilly (LLY) and Roche (RHHBY)'s Failed 6/29/2017
TiGenix Begins Recruiting for New U.S. HQ in Massachusetts 6/29/2017
Two Former Ariad (ARIA) Directors Charged With Insider Trading 6/29/2017
After FDA Rejection, Bay Area's Coherus Axes 30% of Employees 6/29/2017
Merck & Co. (MRK) Becomes Victim of Massive Ransomware Cyber Attack 6/29/2017
GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock 6/29/2017
A Look at the Deaths That Plagued Juno (JUNO) and Kite Pharma (KITE)'s CAR-T Trials 6/29/2017
Dimension Therapeutics (DMTX) Pink Slips 25% of Workforce 6/28/2017
Elephants Rarely Get Cancer and Why That’s Good News for Pet Owners and Us 6/28/2017
What Makes Biogen (BIIB) and Bristol-Myers Squibb (BMY) Such Attractive Takeover Targets 6/28/2017
Pharma Bro Martin Shkreli Manages to Elect Five Pals to Turing's Board Before Trial 6/27/2017
2 Biotech Stocks That Exploded 500%+ in the Last 3 Years 6/27/2017
Genentech (RHHBY)'s Hemophilia Blockbuster Contender Hits Phase III Goals, But Questions Remain 6/27/2017
Bay Area's Portola (PTLA) Rockets as the FDA Approves First and Only Anticoagulant for Hospitals 6/27/2017
Investors Relieved as Seattle Genetics (SGEN) Pulls Out Win for Phase III Lymphoma Trial 6/27/2017
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's 6/26/2017
Genentech (RHHBY) Wins No. 1 Top Spot as The Ideal Employer in Life Sciences 6/23/2017
Survey Says: Here Are the 4 Most-Liked Life Science CEOs 6/23/2017
5 Biotechs Quietly Hitting Unusual Volumes Right Now 6/23/2017
12 Careers for Life Scientists Outside of the Lab 6/23/2017
15 In-Demand Life Science Jobs in Northern California 6/23/2017
3 Biotech Stocks That Look Like Apple (AAPL) Did in the 1980s 6/23/2017
Insiders Just Bought $234 Million Worth of These Pharma Stocks 6/22/2017
3 Pharma Stocks Billionaire Izzy Englander Bought Recently 6/22/2017
PAREXEL (PRXL) Sold to Investment Firm in $5 Billion Deal 6/22/2017
Novartis AG (NVS) Rejects Trump's Proposition to Create More U.S Jobs 6/22/2017
Repare Therapeutics Bursts From Stealth Mode With $68 Million and a Team Packed With Industry Alums 6/22/2017
More Deaths Lead Seattle Genetics (SGEN) to Discontinue Phase III Leukemia Study 6/21/2017
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles 6/21/2017
Massachusetts Biotech Startup Sigilon Launches With $23.5 Million 6/21/2017
Tiny New York Biotech With Ties To Massachusetts, Syntimmune, Gets A $50 Million Boost 6/21/2017
A Look at the 5 Most Profitable Biopharma Companies 6/21/2017
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals 6/21/2017
Warning: These Could be the Top 3 Most Overrated Biotech Stocks 6/20/2017
Faltering Enumeral Biomedical (ENUM) Cuts R&D Staff, Alters Executive Compensation Deal 6/20/2017
Gilead (GILD), Sanofi (SNY) Reportedly Bidding on This $10 Billion Massachusetts Biotech 6/16/2017
Why This Bay Area Biotech Could Be the Best-in-Breed for 2017 6/16/2017
After Bagging Patheon (PTHN) for $7.2 Billion, This Could be Thermo Fisher Scientific (TMO)'s New Target 6/16/2017
What Biogen (BIIB) CFO's Departure Means for Company's M&A Strategy 6/16/2017
Google (GOOG)'s Verily (GOOGL) and Novartis AG (NVS) Jump Into Medicxi's $300 Million Life Science Investment Fund 6/15/2017
Up and Coming Scientist Gets Funding for CAR-T Startup CARMA Therapeutics 6/15/2017
UK Charity to Use $638 Million Cash From Merck & Co. (MRK)'s Blockbuster Keytruda to Back R&D 6/15/2017
Helsinn And MEI Pharma (MEIP) Announce First Patient Dosed In Phase II Dose-Optimization Study Of Pracinostat And Azacitidine In Myelodysplastic Syndrome 6/14/2017
Why Celgene (CELG) Gets No R-E-S-P-E-C-T, But Should 6/14/2017
Massachusetts Biotech iSpecimen Launches Amazon (AMZN)-Like Marketplace for Scientists 6/14/2017
Sanofi (SNY) Commits $673 Million in Biologics 6/14/2017
Disney-Backed Dragonfly Nabs $33 Million From Biotech Bestie Celgene (CELG) 6/13/2017
Why This Tiny New Jersey Biotech Looks Like Oracle in 1986 6/13/2017
What Biogen (BIIB) Wants in Return for Financial Assistance of Its $750,000 a Year Drug 6/13/2017
Bristol-Myers Squibb (BMY) Asks for Patience as Takeover Chatter Reemerges Post-ASCO 6/12/2017
NantHealth (NH)'s Patrick Soon-Shiong Expands His Empire With Plans to Open a World-Class Cancer Center This Summer 6/12/2017
Sanofi (SNY)'s Rumored Buyout Target Flexion (FLXN) Shows Off Mid-Stage Osteoarthritis Data 6/12/2017
Effective Immediately: Bristol-Myers Squibb (BMY) Exec to Take the Reins at Kleo 6/12/2017
NewLink Genetics (NLNK) Stock Plunges After Genentech (RHHBY) Bails on $1 Billion+ IDO Deal 6/9/2017
16 Questions Top Pharma Applicants Should Ask During the Job Interview 6/9/2017
Smart Biotech Careers for Job Seekers With No PhD 6/9/2017
Investment Group Just Paid $605 Million for This Bay Area Pharma 6/9/2017
Top 10 Life Science Job Trends in 2017 6/9/2017
Bristol-Myers Squibb (BMY) Loses $4.3 Billion in Market Value After ASCO Update 6/8/2017
Why This Seattle Biotech's Stock Has More Than Doubled in 8 Months 6/8/2017
The 1 Pharma Stock That Feels Like Microsoft in 1986 6/8/2017
This Small Massachusetts Biotech Soared to a 20-Month High on Its Celgene (CELG)-Partnered Trial 6/8/2017
Bomb Scare Leads to Evacuation at Pfizer (PFE) Plant 6/7/2017
PE Firms Take Out New York's AMRI (AMRI) for $922 Million Cash 6/7/2017
Unknown Nanjing Legend Emerges as a CAR-T Phenom at ASCO 6/7/2017
Bay Area GRAIL's Billion Gamble on the Perfect Cancer Test 6/7/2017
2 Small Biotechs Whose ASCO Presentations Could Kick Stocks Higher 6/6/2017
7 Biotechs and Pharmas That Have the Potential to Double (or More) 6/6/2017
Investors Sigh With Relief as bluebird bio (BLUE), Celgene (CELG)'s CAR-T Candidate Keeps Multiple Myeloma Patients Relapse Free 6/5/2017
Down but Not Out, Juno (JUNO) Fights Back with Positive CAR-T Results in its JCAR017 Program 6/5/2017
Stock Tanks as Endocyte (ECYT) Cuts 40% of Workforce, Slashes 2 Clinical Programs 6/5/2017



//-->